The recent publication of The Lancet Commission on pollution and health is a watershed moment for one of the greatest challenges to cardiovascular health. In this Comment article, we discuss the global burden of air pollution on cardiovascular health. NATURE REVIEWS | CARDIOLOGY VOLUME 15 | APRIL 2018 | 193 COMMENT © 2 0 1 8 M a c m i l l a n P u b l i s h e r s L i m i t e d , p a r t o f S p r i n g e r N a t u r e . A l l r i g h t s r e s e r v e d .
Cardiovascular disease (CVD) is the leading cause of death worldwide, responsible for >17 million pre mature deaths in 2016 (REF. 1 ). Notably, >3 million of these deaths (19% of all cardiovascular deaths) are attributable to air pollution 1 . The Lancet Commission on Pollution and Health aims to raise global awareness of the effects of pollution on overall health through six recommenda tions 2 . In this Comment article, we evaluate how these recommendations can reduce the harmful effects of air pollution on cardiovascular health.
Air pollution exposures are often ascribed to two categories: household pollution and ambient pollution. Approximately 3 billion people are exposed to house hold air pollution emitted from cooking and heating with inefficient stoves that burn biomass and coal fuels 1, 2 . Nearly all individuals worldwide are exposed to ambient air pollution that originate from traffic, industrial facili ties, and agricultural burning [1] [2] [3] [4] . In 2016, ambient air pollution and household air pollution were respon sible for 2.3 million and 1.2 million cardiovascular deaths, respectively 1 . The overwhelming majority of this burden is shouldered by lowincome and middleincome countries. Mortality is also higher in certain susceptible subpopulations, including individuals of advanced age and lower socioeconomic status, and those with other traditional cardiovascular risk factors 1, 3, 5 . Fine particulate matter air pollution (particles >2.5 μm in diameter, or PM 2.5 ) is the pollutant with the most compelling observational and experimental evidence of association with increased risk of cardio vascular mortality [1] [2] [3] [4] [5] [6] . PM 2.5 is composed of elemental carbon, transition metals, sulfates, nitrates, and complex organic molecules, and originates from household wood and coal burning, industrial facilities, vehicle emis sions, and agricultural burning [3] [4] [5] [6] . These small particles can enter lung alveoli, triggering the release of proin flammatory mediators and vasculoactive molecules, which result in oxidative stress, systemic inflammation, endothelial dysfunction, vasoconstriction, and auto nomic imbalance [3] [4] [5] [6] . Consequently, acute exposures to PM 2.5 can increase the risk of acute coronary syndrome, heart failure, venous thromboembolism, arrhythmia, and cardiac arrest [3] [4] [5] [6] . Furthermore, chronic exposure to PM 2.5 can increase the risk of developing hypertension, type 2 diabetes, and atherosclerosis, together increasing the risk of cardiovascular death. Conversely, reducing exposure to air pollution has been shown to decrease the immediate risk of acute coronary syndromes, arrhyth mias, heart failure, and the longterm development and progression of atherosclerosis 3, 5, 6 . The Clean Air Act increased regulation of industrial and vehicular particu late matter emissions, preventing an estimated 130,000 myocardial infarction events in the USA in 2010 (REF. 7 ).
The dose-response relationship between air pollu tion and CVD has been described using integrated exposure-response curves, which estimate the relative risk of different cardiovascular events at various levels of PM 2.5 exposure 8 . The risk of ischaemic heart disease and stroke associated with PM 2.5 exposure is supralinear; that is, the relationship is strongest at lower concentra tions, and becomes weaker as air pollution increases. The shape of this curve implies that substantial health benefits will accrue only from interventions that reduce exposures to low levels. Consequently, improvements in cardio vascular health might be more difficult to achieve in communities suffering a greater burden of air pollution.
The Lancet Commission provided detailed recom mendations for reducing air pollution exposures across populations, including the governmentdriven develop ment of comprehensive, datadriven, and publicly available action plans with clear targets for combating pollution 2 . A crucial part of this plan is the implemen tation and enforcement of regulations, sub sidies, and penalties to shift economies towards affordable and renewable energy sources, cleaner vehicles, and reduced industrial emissions. Investments must be made to develop healthtracking systems with highquality metrics to monitor air pollution exposure levels, the burden of pollution attributable CVD, and the effect of interventions. Finally, a dedicated international funding pool is needed to finance research and interventions, particularly in lowresource settings. Implementing the Commission's recommendations will do much to address pollutionattributable CVD at the level of populations and organizations. However, these recommendations must be paired with pro grammes that empower individuals to protect them selves from the harmful effects of air pollution within their own microenvironment (FIG. 1) . Clinicians and healthcare workers can be taught to screen individ uals for pollution exposures based on household use of solid fuels and proximity to urban or industrial centres. Pollution exposures can be quantified in a variety of ways, including groundbased monitoring, satellite measurements, personal detection systems, and regres sion models that predict exposures based on home fuel use, proximity to traffic, and other factors.
To date, no randomized trials have investigated the efficacy of pollutionreducing interventions on cardiac outcomes. However, data from studies investigating intermediate end points (such as blood pressure and inflammatory markers) support the use of several inter ventions 3, 5 . Individuals identified as particularly vulner able to pollutionattributable CVD can be provided with cleanburning stoves and fuel, improved household ventilation devices, and airfiltration devices, and can be educated on the use of automated air pollution alert networks and strategies to reduce exposures to traffic and industrial emissions. Additionally, clinicians should emphasize treatment of traditional cardiovascular risk factors to these atrisk individuals. Such interventions often benefit from partnership with governments, nongovernmental organizations, or insurance providers.
Extensive research is still needed to quantify expo sures and validate interventions to reduce the burden of pollutionattributable CVD 2 . Important future tasks include: the development of a model to estimate individ ual absolute risk of cardiac events based on pollution exposure levels and comorbidities; calculation of how much pollution exposure levels must be reduced in order to achieve cardiovascular benefits; and determination of the relationship between cardiovascular health and other air pollutants, such as nitrogen dioxide, carbon monoxide, sulfur dioxide, and other volatile organic compounds. Furthermore, the efficacy, feasibility, costeffectiveness, and cobenefits (such as increased productivity or reduced greenhouse gas emissions) of interventions to reduce ambient and household air pollu tion exposures should be calculated, and both health and environmental benefits of reducing pollution should be characterized. To guide these investigations, a consortium should provide standard research methods and facilitate data aggregation and metaanalysis 9 . The burden of pollutionattributable disease is shoul dered disproportionately by lowincome and middle income countries, which account for >99% of deaths due to household air pollution and 89% of deaths due to ambient air pollution 2 . Moreover, within countries, the burden of pollutionassociated disease is most concen trated among children, women, the elderly, and the poor. This disease burden is an infringement on the human right to a healthy environment, and a threat to equal protection of environmental laws and regulations 2 . The global health community has a critical window of oppor tunity to invest in research, regulation, and interven tion, particularly among lowresource communities, to reduce the global burden of pollutionattributable CVD.
